Saba Capital Management Amends 13D Filing for Nuveen Fund

Ticker: JRI · Form: SC 13D/A · Filed: Aug 2, 2024 · CIK: 1539337

Nuveen Real Asset Income & Growth Fund SC 13D/A Filing Summary
FieldDetail
CompanyNuveen Real Asset Income & Growth Fund (JRI)
Form TypeSC 13D/A
Filed DateAug 2, 2024
Risk Levelmedium
Pages4
Reading Time5 min
Key Dollar Amounts$0.01, $19,000,686
Sentimentneutral

Sentiment: neutral

Topics: 13D-filing, activist-investor, closed-end-fund

TL;DR

Saba Capital updated its 13D filing for Nuveen Real Asset Income & Growth Fund. Watch this space.

AI Summary

Saba Capital Management, L.P. filed an amendment (No. 6) to its Schedule 13D on August 2, 2024, regarding Nuveen Real Asset Income & Growth Fund. The filing indicates a change in beneficial ownership as of July 31, 2024, with Saba Capital Management GP, LLC and Boaz R. Weinstein listed as group members.

Why It Matters

This amendment signals potential shifts in significant shareholder positions and strategies concerning the Nuveen Real Asset Income & Growth Fund.

Risk Assessment

Risk Level: medium — Schedule 13D filings often precede activist campaigns or significant trading activity, indicating potential volatility.

Key Players & Entities

  • Saba Capital Management, L.P. (company) — Filing entity
  • Nuveen Real Asset Income & Growth Fund (company) — Subject company
  • Saba Capital Management GP, LLC (company) — Group member
  • Boaz R. Weinstein (person) — Group member
  • Michael D'Angelo (person) — Authorized contact

FAQ

What is the specific change in beneficial ownership reported in this amendment?

The filing is an amendment (No. 6) to a Schedule 13D, indicating a change in beneficial ownership as of July 31, 2024, but the exact percentage or number of shares changing hands is not detailed in the provided header information.

Who are the key parties involved in this filing?

The filing involves Saba Capital Management, L.P. as the filer, Nuveen Real Asset Income & Growth Fund as the subject company, and lists Saba Capital Management GP, LLC and Boaz R. Weinstein as group members.

When was this amendment filed?

This amendment was filed on August 2, 2024.

What is the CUSIP number for Nuveen Real Asset Income & Growth Fund's common shares?

The CUSIP number for the common shares of Nuveen Real Asset Income & Growth Fund is 67074Y105.

What is the business address of Saba Capital Management, L.P.?

The business address for Saba Capital Management, L.P. is 405 Lexington Avenue, 58th Floor, New York, NY 10174.

Filing Stats: 1,349 words · 5 min read · ~4 pages · Grade level 11 · Accepted 2024-08-02 09:03:08

Key Financial Figures

  • $0.01 — Fund (Name of Issuer) Common Shares, $0.01 par value (Title of Class of Securiti
  • $19,000,686 — ported herein. A total of approximately $19,000,686 was paid to acquire the Common Shares r

Filing Documents

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: August 2, 2024 SABA CAPITAL MANAGEMENT, L.P. By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Chief Compliance Officer SABA CAPITAL MANAGEMENT GP, LLC By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Authorized Signatory BOAZ R. WEINSTEIN By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Attorney-in-fact* * Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823 CUSIP No. 67074Y105 SCHEDULE 13D/A Page 7 of 7 Pages Schedule A This Schedule sets forth information with respect to each purchase and sale of Common Shares which were effectuated by Saba Capital since the filing of the Schedule 13D/A on 7/19/24. All transactions were effectuated in the open market through a broker. Trade Date Buy/Sell Shares Price 7/19/2024 Sell 25,968 12.47 7/22/2024 Sell 32,088 12.52 7/23/2024 Sell 43,262 12.57 7/24/2024 Sell 6,248 12.55 7/25/2024 Sell 52,524 12.49 7/26/2024 Sell 23,984 12.50 7/29/2024 Sell 38,647 12.50 7/30/2024 Sell 39,723 12.51 7/31/2024 Sell 49,095 12.66 8/1/2024 Sell 35,900 12.69

View Full Filing

View this SC 13D/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.